Advisor Group Holdings, Inc. Verrica Pharmaceuticals Inc. Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 568 shares of VRCA stock, worth $4,515. This represents 0.0% of its overall portfolio holdings.
Number of Shares
568
Previous 568
-0.0%
Holding current value
$4,515
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding VRCA
# of Institutions
43Shares Held
15.4MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY8.88MShares$70.6 Million1.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$17.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.13MShares$8.98 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny907KShares$7.21 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA646KShares$5.14 Million0.0% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $327M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...